Disparity between scientific accomplishment and biotechnology availability in Brazil

Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countries for the purchase of essential scientific-related products. Is this sustainable? Therefore it is necessary to draw the attention of all the world and Brazilian society about this situation

URI

https://observatorio.fm.usp.br/handle/OPI/42633

Referências

Brasil em Pauta entrevista o presidente da Capes Benedito Aguiar, BRASIL PAUTA ENTREVI
de Godoy NS, 2020, ASIAN PAC J TROP MED, V13, P62, DOI 10.4103/1995-7645.275414
de Jesus JG, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062030, 10.1590/s1678-9946202062030]
Ioannidis JPA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000918
Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
Ribeiro GD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83879-6
Tozetto-Mendoza TR, 2021, J VIROL METHODS, V290, DOI 10.1016/j.jviromet.2021.114064

Coleções

Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/09

Página do item completo